Dengue Vaccines Market is predicted to account for US$ 1603.7 Million by 2033, with a growth rate of 12.9% CAGR through 2033

The dengue vaccines market is expected to witness significant growth in China, with a projected CAGR of 14.8% over the coming years. Similarly, in India, the market is anticipated to grow at a CAGR of 11.7% by 2033. These projections highlight the increasing demand for dengue vaccines in these regions.

/EIN News/ — NEWARK, Del, May 31, 2023 (GLOBE NEWSWIRE) — The dengue vaccines market will expand, with total revenue expected to exceed US$ 474.8 Million by 2023. The demand for Dengue Vaccines is expected to increase at a CAGR of 12.9% by volume (units).

Dengue vaccine development has reached a crucial milestone, with a slew of pharmaceutical behemoths due to report the results of major clinical trials launched in the last decade or half-decade. The future availability of numerous alternatives is anticipated to break the present Denvaxia® vaccine’s exclusivity.

A variety of worldwide collaborations including healthcare stakeholders from diverse institutional settings are generating more clinical trials and research investigations aimed at developing novel vaccine formulations. The majority of growth is expected to remain focused in the Asia-Pacific region, owing to the highest dengue fever concentration as well as the existence of reputable regional pharmaceutical companies.

Drivers and Challenges have an Impact on Market Dynamics, which can Impact Businesses. Find more details in our Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1763

Because a large percentage of cases are asymptomatic, moderate, or self-managed, the actual number of infections is greatly under-reported. According to one modeling estimate, 390 million dengue virus infections occur each year (95% credible interval 284-528 million), with 96 million presenting clinically.

With the support of national expert groups and the aforementioned programme, India’s market for dengue vaccinations is experiencing a significant shift. Important stakeholders are becoming aware of such joint activities, which is supporting important pharmaceutical businesses in making substantial advances in vaccine research. This is expected to boost the global dengue vaccines market’s growth prospects in the approaching years.

Key Takeaway

• Over the historical period, the worldwide market grew at an 11.9% CAGR.
• Over the next several decades, the Chinese market is expected to grow at a CAGR of 14.8%.
• The United States has emerged as a key market, accounting for more than 16.5% of overall demand in 2022.
• The Indian market is expected to grow at a CAGR of 11.7% in the future decades.
• In 2022, the Government Institutes category had a market share of Government Institutes.

“As a result, the worldwide dengue fever prevalence burden is mostly concentrated in Asian nations, major pharmaceutical businesses are projected to discover lucrative income streams in India, Japan, and South East Asia.” says an FMI analyst.

Are you looking for more details about the latest trends, drivers, and challenges? Speak to Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1763

Competitive Landscape

The renowned firm’s primary expansion strategy remains clinical trials to create several vaccine candidates. Market participants are effectively exploiting strategic collaborations with big pharmaceutical businesses or research institutions, mergers and acquisitions, and capacity expansion projects to accomplish this.

• Takeda revealed in May 2023 that their dengue vaccine QDENGA® has gained various authorizations, which includes one from Brazil’s National Health Surveillance Agency in March 2023 for use in persons aged 4 to 60 years to safeguard against all four serotypes.
• Argentine health officials have approved the application of a Japanese dengue vaccine that must be provided in two doses three months distant, according to a story in Buenos Aires in April 2023.

Key Players:

• Sanofi Pasteur Limited
• Takeda Pharmaceutical Company Limited
• Merck & Co. Inc.
• GlaxoSmithKline Plc.
• GeneOne Life Science Inc.
• Medigen Vaccine Biologics Corporation
• Panacea Biotec Limited
• Sun Pharmaceutical Industries Ltd
• Serum Institute of India Pvt. Ltd.
• Biological E Ltd.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the Global Dengue Vaccines market presenting a historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights by Product (CYD-TDV (Dengvaxia)), End-User, Hospitals, Government Institutes, and Non-governmental Organizations NGOs) & Region.

Buy Now and Gain Access to Identify Key Trends, Drivers, and Challenges in the Market @ https://www.futuremarketinsights.com/checkout/1763

Key Segments Covered

Product:

End-User:

• Hospitals
• Government Institutes
• Non-governmental Organizations (NGOs)

Region:

• North America (USA and Canada)
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Table of Content
1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. CYD-TDV (Dengvaxia)

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

Complete TOC: https://www.futuremarketinsights.com/toc/rep-gb-1763

Have a Look at Related Research Reports in the Healthcare Domain:

Dental Simulator Market Size: The dental simulator market is expected to increase from US$ 368.8 million in 2023 to US$ 780.5 million in 2033. The dental simulator business is anticipated to capture a CAGR of 7.8% between 2023 and 2033.

Sleep Apnea Implants Market Share: The sleep apnea implants market size is estimated to be valued at US$ 317.1 million in 2023 and is expected to reach US$ 1,158.1 million by 2033. The adoption of Sleep Apnea Implants is likely to advance at a CAGR of 13.8% during the forecast period.

Laser Therapy Devices Market Growth: The laser therapy devices market size is estimated to be valued at US$ 3 billion in 2023 and is expected to reach US$ 7 billion by 2033. The adoption of laser therapy devices is likely to advance at a CAGR of 8.8% during the forecast period.

DNA Polymerase Market Trend: The DNA polymerase market is likely to register positive growth with the overall valuation forecast to reach US$ 353.9 million in 2023. The demand for DNA Polymerases is projected to surge with a projected CAGR of 6.2% to reach US$ 647.5 million.

Prostate-Specific Antigen Testing Market Forecast: According to Future Market Insights research, during the projected period, the global prostate-specific antigen (PSA) testing market is expected to grow at a CAGR of 12.0%. The market value is projected to increase from US$ 6.3 Billion in 2023 to US$ 19.5 billion by 2033.

Neonatal Thermoregulation Market Analysis: The global neonatal thermoregulation market is estimated at US$ 661.8 million in 2023. The market is projected to reach US$ 1,151.6 million by 2033, exhibiting a CAGR of 5.7% from 2023 to 2033.

High Content Screening Market Sales: The high content screening market will register positive growth with the overall valuation forecast to reach US$ 1.6 billion in 2022. The demand for high-content screening is projected to surge with a projected CAGR of 5.8%.

Gene Prediction Tools Market Outlook: The global gene prediction tools market size is projected to be worth US$ 127.3 million in 2023. The market is likely to surpass US$ 680.9 million by 2033. It is set to expand at a CAGR of 18.3% during the forecast period.

Veterinary Sutures Market Volume: According to Future Market Insights research, during the projected period, the global veterinary sutures market is expected to grow at a CAGR of 3.8%. The market value is projected to increase from US$ 333.38 Million in 2023 to US$ 482.1 Million by 2033.

Robotic Lung Biopsy Market Application: The robotic lung biopsy market size is projected to be worth US$ 408.0 million in 2023. From 2023 to 2033, global robotic lung biopsy demand is forecast to rise at 9.6% CAGR. Total market valuation at the end of 2033 is expected to surpass US$ 1,023.05 million.

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.

Contact Us:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: [email protected]